疑似注射水货九价HPV疫苗,接种者在港起诉诊所获判退款

2019-09-01 吕新文 吴跃伟 实习生 汪萌菲 澎湃新闻

因为怀疑接种了水货九价人乳头瘤病毒(亦称“HPV”)疫苗,此前到香港“环亚体检集团有限公司”(下称“环亚体检”)接种疫苗的多名接种者将诊所告上法庭,8月29日,香港小额钱债审裁处裁定环亚体检赔偿接种者疫苗费用、交通费用及诉讼费。8月30日晚,来自东北的吴女士说,她于29日到香港特区西九龙法院出庭,环亚体检方面并未派人到庭发表意见。29日下午5时该案开庭,经过约1个小时的庭审,29日下午6时许,法官

因为怀疑接种了水货九价人乳头瘤病毒(亦称“HPV”)疫苗,此前到香港“环亚体检集团有限公司”(下称“环亚体检”)接种疫苗的多名接种者将诊所告上法庭,8月29日,香港小额钱债审裁处裁定环亚体检赔偿接种者疫苗费用、交通费用及诉讼费。

8月30日晚,来自东北的吴女士说,她于29日到香港特区西九龙法院出庭,环亚体检方面并未派人到庭发表意见。29日下午5时该案开庭,经过约1个小时的庭审,29日下午6时许,法官支持包括她在内的5名接种者提出的诉讼请求,裁定涉事诊所赔偿相应费用。

另据财新网报道,8月29日,香港法院支持14名申请人的索赔要求,裁定环亚体检须向14名申请人支付疫苗退款及诉讼费合计约9.5万港元。

吴女士说,自己提出的赔偿金额为8000多港币,包括疫苗针款、交通费用及诉讼费用,其他接种者提出的索赔金额在7000至8360港币不等。虽然已经胜诉,但吴女士仍需等待法院进一步通知,她说,小额钱债审裁处表示会将判决结果告知环亚体检,若法院无法找到联系到诊所负责人,她可能仍需要前往香港,通过其他途径追讨赔偿款。

据香港司法机构官网介绍,香港小额钱债审裁处负责处理低于7.5万元的金钱申索,主要处理债务、服务费、财物损毁、已售货物及消费者提出的各类申索。如果审裁官判某一方胜诉,但是败诉方却没有遵照判决付款,则胜诉方可以通过审裁处,向特区司法机构的执达主任办事处申请《扣押债务人财产令状》以强制执行判决。

据此前报道,5月9日,九价HPV疫苗全球唯一生产商默沙东药厂香港公司发布声明表示,其未向环亚体检供货九价HPV疫苗。6月5日,环亚体检在位于香港佐敦嘉宾商业大厦的办事处张贴通告称,已完成1000万元港币退款,因为公司银行账户被冻结、负责人惹上官司,宣布“清盘结业”,多名接种者面临打不上针又无法收到退款的情况。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2071383, encodeId=30ba20e13831a, content=<a href='/topic/show?id=357d23492a6' target=_blank style='color:#2F92EE;'>#九价HPV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23492, encryptionId=357d23492a6, topicName=九价HPV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Wed Jul 29 02:30:00 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998506, encodeId=62be199850644, content=<a href='/topic/show?id=20a95669854' target=_blank style='color:#2F92EE;'>#接种者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56698, encryptionId=20a95669854, topicName=接种者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af60254, createdName=mhm289, createdTime=Wed Nov 13 10:30:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311176, encodeId=7be413111e629, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Tue Sep 03 13:30:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499916, encodeId=f278149991676, content=<a href='/topic/show?id=d6e292e2609' target=_blank style='color:#2F92EE;'>#起诉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92726, encryptionId=d6e292e2609, topicName=起诉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=548d9387874, createdName=huirong, createdTime=Tue Sep 03 13:30:00 CST 2019, time=2019-09-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2071383, encodeId=30ba20e13831a, content=<a href='/topic/show?id=357d23492a6' target=_blank style='color:#2F92EE;'>#九价HPV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23492, encryptionId=357d23492a6, topicName=九价HPV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Wed Jul 29 02:30:00 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998506, encodeId=62be199850644, content=<a href='/topic/show?id=20a95669854' target=_blank style='color:#2F92EE;'>#接种者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56698, encryptionId=20a95669854, topicName=接种者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af60254, createdName=mhm289, createdTime=Wed Nov 13 10:30:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311176, encodeId=7be413111e629, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Tue Sep 03 13:30:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499916, encodeId=f278149991676, content=<a href='/topic/show?id=d6e292e2609' target=_blank style='color:#2F92EE;'>#起诉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92726, encryptionId=d6e292e2609, topicName=起诉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=548d9387874, createdName=huirong, createdTime=Tue Sep 03 13:30:00 CST 2019, time=2019-09-03, status=1, ipAttribution=)]
    2019-11-13 mhm289
  3. [GetPortalCommentsPageByObjectIdResponse(id=2071383, encodeId=30ba20e13831a, content=<a href='/topic/show?id=357d23492a6' target=_blank style='color:#2F92EE;'>#九价HPV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23492, encryptionId=357d23492a6, topicName=九价HPV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Wed Jul 29 02:30:00 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998506, encodeId=62be199850644, content=<a href='/topic/show?id=20a95669854' target=_blank style='color:#2F92EE;'>#接种者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56698, encryptionId=20a95669854, topicName=接种者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af60254, createdName=mhm289, createdTime=Wed Nov 13 10:30:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311176, encodeId=7be413111e629, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Tue Sep 03 13:30:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499916, encodeId=f278149991676, content=<a href='/topic/show?id=d6e292e2609' target=_blank style='color:#2F92EE;'>#起诉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92726, encryptionId=d6e292e2609, topicName=起诉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=548d9387874, createdName=huirong, createdTime=Tue Sep 03 13:30:00 CST 2019, time=2019-09-03, status=1, ipAttribution=)]
    2019-09-03 ycmayy
  4. [GetPortalCommentsPageByObjectIdResponse(id=2071383, encodeId=30ba20e13831a, content=<a href='/topic/show?id=357d23492a6' target=_blank style='color:#2F92EE;'>#九价HPV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23492, encryptionId=357d23492a6, topicName=九价HPV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Wed Jul 29 02:30:00 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998506, encodeId=62be199850644, content=<a href='/topic/show?id=20a95669854' target=_blank style='color:#2F92EE;'>#接种者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56698, encryptionId=20a95669854, topicName=接种者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af60254, createdName=mhm289, createdTime=Wed Nov 13 10:30:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311176, encodeId=7be413111e629, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Tue Sep 03 13:30:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499916, encodeId=f278149991676, content=<a href='/topic/show?id=d6e292e2609' target=_blank style='color:#2F92EE;'>#起诉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92726, encryptionId=d6e292e2609, topicName=起诉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=548d9387874, createdName=huirong, createdTime=Tue Sep 03 13:30:00 CST 2019, time=2019-09-03, status=1, ipAttribution=)]
    2019-09-03 huirong

相关资讯

侠客岛解析芬太尼:注射后1分钟起效,甚至可用作化学武器

昨天,中美两国元首会晤后,世界各大媒体第一时间报道了中美贸易战停火的消息。有意思的是,白宫关于会晤的声明中,有一个对中国大众相当陌生的名词,却被排在贸易问题、高通并购和半岛局势之前:芬太尼(Fentanyl)。白宫说,“中国以一种高尚的人道主义姿态,同意将芬太尼指定为一种受控物质,这意味着向美国出售芬太尼的人将受到中国法律规定的最高刑罚。”两国领导人相见,排在声明第一位的居然是不太为大众所熟知

静脉铁剂的区别及注意事项

静脉铁剂主要有蔗糖铁(IS,蔗糖酸铁)、低分子右旋糖酐铁(ID)、羧基麦芽糖铁(FCM)、异麦芽糖酐铁、葡萄糖醛酸铁、纳米氧化铁、山梨醇铁等。临床可用于缺铁性贫血、肾性贫血、围手术期贫血等。

“老糖友”对其他注射部位定位不准,护士发明胰岛素腿部定位带获点赞

老糖友林婆婆反复在同一部位注射胰岛素,致该部位皮下脂肪增生,降低了药物吸收效率,血糖依旧居高不下。武汉市中心医院后湖院区内分泌科管床护士张冬雪了解到她是因为对胰岛素腿部定位不准才总是注射腹部,于是熬夜缝制“胰岛素腿部定位带”,并拟在科室推广,获患者点赞。林婆婆有6年糖尿病病史,为控制好血糖,从去年起她每天都得注射胰岛素。近一周来,林婆婆遇到怪事,每天按时注射胰岛素但血糖依旧居高不下,于是带着疑问

江苏常熟一患者被注射过期葡萄糖:暂无异常,调查结果将公布

5月8日,记者从江苏常熟市委宣传部获知,此前被使用了过期钠钾镁钙葡萄糖注射液的患者,目前状态稳定没有出现异常反应。当地卫健委正就该事件展开调查,调查结果将于近日出炉。5月1日,正在常熟市第一人民医院接受胆囊炎及肝脓肿治疗的陶某被家人发现,其被注射的钠钾镁钙葡萄糖注射液有效期至2018年12月27日,当时已过期超过5个月。6日,常熟市卫健委对该事故开始开展调查。常熟市委宣传部新闻科科长王启罡介绍,陶

Science:新型口服胰岛素,或将取代传统注射

近日,美国麻省理工学院(MIT)领导的一个研究团队开发了一种可以口服的胰岛素胶囊,有望取代2型糖尿病患者每天必须使用的注射型胰岛素。

水肿病人怎么做皮试?送你两种特殊方法

当你遇到水肿病人需要做皮试时,面对皮试部位的水肿,如何应对?